viernes, 10 de julio de 2026

FDA approves isatuximab-irfc for subcutaneous injection for multiple myeloma indications

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-isatuximab-irfc-subcutaneous-injection-multiple-myeloma-indications?utm_medium=email&utm_source=govdelivery

No hay comentarios:

Publicar un comentario